{"id":793,"date":"2007-06-24T15:11:58","date_gmt":"2007-06-24T20:11:58","guid":{"rendered":"http:\/\/www.sequence-inc.com\/fraudfiles\/2007\/06\/24\/when-is-a-public-company-required-to-file-a-form-8-k\/"},"modified":"2007-06-24T15:13:01","modified_gmt":"2007-06-24T20:13:01","slug":"when-is-a-public-company-required-to-file-a-form-8-k","status":"publish","type":"post","link":"https:\/\/www.sequenceinc.com\/fraudfiles\/when-is-a-public-company-required-to-file-a-form-8-k\/","title":{"rendered":"When is a public company required to file a Form 8-K?"},"content":{"rendered":"

Several people have questioned whether Usana Health Sciences must file a Form 8-K with the SEC to notify them of the recent distributor class action suit<\/a>. It seems to be the common belief that the lawsuit is a “material event” requiring the filing of an 8-K.<\/p>\n

So here it is, straight from the Securities and Exchange Commission. Yes, the suit may be considered a material event, but the 8-K only needs to be filed if the material even falls under one of the below categories:<\/p>\n

In addition to filing annual reports on Form 10-K and quarterly reports on Form 10-Q, public companies must report material corporate events on a more current basis. Form 8-K is the \u201ccurrent report\u201d companies must file with the SEC to announce major events that shareholders should know about.<\/p>\n

The instructions for Form 8-K<\/a> describe the types of events that trigger a public company’s obligation to file a current report, including any of the following:
\nSection 1 — Registrant’s Business and Operations
\nItem 1.01 Entry into a Material Definitive Agreement
\nItem 1.02 Termination of a Material Definitive Agreement
\nItem 1.03 Bankruptcy or Receivership<\/p>\n

Section 2 — Financial Information
\nItem 2.01 Completion of Acquisition or Disposition of Assets
\nItem 2.02 Results of Operations and Financial Condition
\nItem 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
\nItem 2.04 Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
\nItem 2.05 Costs Associated with Exit or Disposal Activities
\nItem 2.06 Material Impairments<\/p>\n

Section 3 — Securities and Trading Markets
\nItem 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
\nItem 3.02 Unregistered Sales of Equity Securities
\nItem 3.03 Material Modification to Rights of Security Holders<\/p>\n

Section 4 — Matters Related to Accountants and Financial Statements
\nItem 4.01 Changes in Registrant’s Certifying Accountant
\nItem 4.02 Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review<\/p>\n

Section 5 — Corporate Governance and Management
\nItem 5.01 Changes in Control of Registrant
\nItem 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
\nItem 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
\nItem 5.04 Temporary Suspension of Trading Under Registrant’s Employee Benefit Plans
\nItem 5.05 Amendment to Registrant’s Code of Ethics, or Waiver of a Provision of the Code of Ethics<\/p>\n

Section 6 — Reserved (for future use)<\/p>\n

Section 7 — Regulation FD Disclosure<\/p>\n

Section 8 — Other Events
\nItem 8.01 Other Events (The registrant can use this Item to report events that are not specifically called for by Form 8-K, that the registrant considers to be of importance to security holders.)<\/p>\n

Section 9 — Financial Statements and Exhibits
\nItem 9.01 Financial Statements and Exhibits<\/p><\/blockquote>\n

It doesn’t appear to me that Usana’s class action suit falls under any of the above criteria. The company could choose to file under Section 8, but is not required to. <\/a> <\/a> <\/a><\/a><\/a> <\/a> <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Several people have questioned whether Usana Health Sciences must file a Form 8-K with the SEC to notify them of the recent distributor class action suit. It seems to be the common belief that the lawsuit is a “material event” […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[5],"tags":[],"class_list":["post-793","post","type-post","status-publish","format-standard","hentry","category-fraud-news-stories"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_shortlink":"https:\/\/wp.me\/p6Z0e-cN","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.sequenceinc.com\/fraudfiles\/wp-json\/wp\/v2\/posts\/793","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sequenceinc.com\/fraudfiles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sequenceinc.com\/fraudfiles\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sequenceinc.com\/fraudfiles\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sequenceinc.com\/fraudfiles\/wp-json\/wp\/v2\/comments?post=793"}],"version-history":[{"count":0,"href":"https:\/\/www.sequenceinc.com\/fraudfiles\/wp-json\/wp\/v2\/posts\/793\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.sequenceinc.com\/fraudfiles\/wp-json\/wp\/v2\/media?parent=793"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sequenceinc.com\/fraudfiles\/wp-json\/wp\/v2\/categories?post=793"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sequenceinc.com\/fraudfiles\/wp-json\/wp\/v2\/tags?post=793"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}